TRI ORIGIN MINERALS LTD
|
|
- Leo Anthony
- 5 years ago
- Views:
Transcription
1 TRI ORIGIN MINERALS LTD Mines And Wines Conference September 2007 Woodlawn Zinc-Copper Projects ASX Code: TRO
2 DISCLAIMER The Information contained in this presentation has been prepared using the information available to Tri Origin Minerals Limited ( TRO ) at the time of preparation. This presentation contains forwardlooking statements that were based on expectations, estimates and projections as of the date of this presentation. Any forward-looking statement is subject to known and unknown factors which may cause actual results and developments to materially differ from those expressed by, or implied by the forward-looking statements in this presentation. External or other factors may have impacted on the business of Tri Origin Minerals and the content of this presentation since its preparation. Tri Origin Minerals does not undertake to update any forward-looking statements that are contained in this presentation, except in accordance with applicable securities laws. In addition, this presentation may not include all relevant information regarding Tri Origin Minerals. Tri Origin Minerals has taken all reasonable care in preparation of this presentation. However, the content of this presentation should not be relied upon in relation to any further action including investment in Tri Origin Minerals. Any person considering an investment in Tri Origin Minerals is advised to obtain independent financial advice prior to making an investment decision. Nothing in this presentation should be construed as to constitute an offer, invitation or recommendation to subscribe for, sell or purchase any security in any jurisdiction. Further information about Tri Origin Minerals is available at:
3 OVERVIEW The Rise Of The Phoenix Woodlawn Underground Woodlawn Retreatment Woodlawn Exploration Lachlan Fold Belt Exploration
4 GROWTH STRATEGY Develop Woodlawn Underground Operation Develop Woodlawn Retreatment Operation Discoveries Away From Existing Resources Offtake & Other Commercial Alliances
5 TRI ORIGIN RESOURCE BASE RELATIVE IN SITU METAL VALUES Total Resources Au 4% Ag 6% 20% Cu Mt Cu (%) Pb (%) Zn (%) Au (g/t) Ag (g/t) Measured % Pb Indicated % Zn Inferred TOTAL August 2007 Excludes Woodlawn North Tailings Dam Mineralisation Includes 6.6 Mt From Lewis Ponds Project
6 WOODLAWN Opportunity For An Integrated Underground And Retreatment Operation
7 WOODLAWN SETTING Veolia Site Operations Significant Infrastructure Rail Access To Port Skilled Workforce In Area Excellent Exploration Upside Project Startup Potential Approved Mining Lease Existing Infrastructure & Services
8 WOODLAWN UNDERGROUND Resource Category Tonnes % Tonnes Cu (%) Pb (%) Zn (%) Au (g/t) Ag (g/t) Measured 3,600, Indicated 4,980, Inferred 1,520, Total 10,100,
9 WOODLAWN BLOCK MODEL UNMINED RESOURCE BLOCKS (+7% Zn Eq) Looking North West BLOCK MODEL Looking Up And East
10 BFS MINE DESIGN PROCESS
11 UNDERGROUND TEST WORK 2 Stage Cleaning/Regrind (grind optimisation) Head Assay Primary Grind Establishment Rougher Flotation (grind optimisation) 2 Stage Cleaning/Regrind (test flow sheet) Locked Cycle Variability Tests 2 Stage Cleaning/Regrind (reagent optimisation) Current Stage Of Evaluation
12 THREE TAILINGS DAMS North Dam Previously Retreated South & West Dams - Not Retreated
13 WOODLAWN TAILINGS RESOURCE Resource Category Tonnes % Tonnes Cu (%) Pb (%) Zn (%) Au (g/t) Ag (g/t) Measured 3,890, Indicated 3,090, Inferred 1,610, Total 8,590, Potential For Up To Additional 2.5Mt In The North Dam
14 TAILINGS TEST WORK FLOWSHEET Cu & Pb Rougher Composite Dam Samples Grind Establishment Cu Rougher & Regrind Zn Tests on Cu & Pb Cleaning Zn Cleaner Cu, Pb & Zn Rougher & Cleaner Pb Rougher & Regrind Current Stage Of Evaluation POTENTIAL TO PRODUCE THREE CONCENTRATES
15 PROPOSED FLOW SHEETS Underground Project Crushing, Grinding Flotation Rougher/Cleaner Con Circuits Regrind To P80 ~25 micron Three Concentrates (Cu, Pb, Zn) ~80,000 tpa Design Throughput Rate ~400,000 tpa Retreatment Project Flotation (~1.5 Mtpa) Regrind Potential For Three Concentrates (Cu, Pb, Zn) >40,000 tpa Blend Retreatment And Underground Concentrates (?)
16 DEVELOPMENT KEY ISSUES Underground Project Resource Conversion To Reserve Mining Method For Sustainable Production Retreatment Project Metal Recoveries Site Rehabilitation Strategy Statutory Approvals
17 POTENTIAL DEVELOPMENT SCENARIO Project Year Woodlawn U/G? Tailings Retreatment Woodlawn Satellite??? Lewis Ponds U/G??? Development planned Operations Planned Potential Combined Operating Life of Plus 14 Years 2 Projects
18 WOODLAWN EXPLORATION World Class Zinc Province Potential To Define Significant Resources Polymetallic Geological Environment Trucking Distance Of Woodlawn
19 CULLERIN JOINT VENTURE EL 6292 TRO Earning 51% Historical Drill Data Hole No From (m) To (m) Interval (m) Au (g/t) Cu (%) Zn (%) WL WL WL WL WL
20 CULLERIN JV
21 LEWIS PONDS PROJECT 2.4 Mt 121g/t Ag, 2.7 g/t Au, 0.2% Cu, 2.6% Pb, 4.0% Zn
22 CONCEPTUAL MINE PLAN
23 SUMMARY NSW Focus Woodlawn Zinc-Copper Projects Multiple Projects Significant Upside Lewis Ponds Future Development Potential Excellent VMS Exploration Portfolio
24 Potential Mkt Cap Growth Target Prod'n 3Q 09 Project Approvals/Funding Mid 08 Project Go Ahead Mid 08 Potential Mkt Cap as at 1Q08 BFS Results 1Q 08 GROWTH POTENTIAL Woodlawn BFS Progress To Date Relative Market Capitalisation 2004 Company raised $5 M Sep 06 - Veolia agreement Oct 06 - Underground Resources Mkt Cap as at Jan 07 June 07 Tailings Resources Commercial Agreements
Disclaimer. Matrix Metals Limited Presentation October
Matrix Metals Limited Presentation October 2008 Disclaimer The material used is this presentation is intended to be a summary of selected geological data, current and proposed activities, as well as resource
More informationMutiny continues to hit high grade gold and copper intersections in latest Deflector drilling
Mutiny continues to hit high grade gold and copper intersections in latest Deflector drilling New Diamond drill results within the Deflector Deposit include: 3.3m @ 79g/t Au and 10.5% Cu from 62m in 12DD042
More informationPalmer Deposit 2018 Resource* INDICATED 5.2% Zn, 1.5% Cu, 30.8 g/t Ag, 0.3 g/t Au INFERRED 5.2% Zn, 1.0% Cu, 29.2 g/t Ag, 0.
14 m RW ZONE EAST upright limb Oxide Mineralization Palmer Deposit Long Section Looking North September 218 TSX-V:CEM steep overturned limb thrust faulted fold hinge SOUTH WALL ZONE I RW ZONE WEST 12 m
More informationFor personal use only
ASX: VRX Diggers & Dealers August 2012 Bruce Maluish, Managing Director www.ventnorresources.com.au 1 Disclaimer & Competent Person This presentation was prepared with due care and attention and is current
More informationJanuary A different kind of Zinc Explorer
January 2018 A different kind of Zinc Explorer Cautionary Statement This presentation contains certain statements that may be deemed "forward-looking statements". All statements in this presentation, other
More informationFirst Results Prospector Drilling Program
24 June 2008 Manager Company Announcements Company Announcements Office Australian Stock Exchange Limited Level 10, 20 Bond Street SYDNEY NSW 2000 ABN 42 082 593 235 Electronic delivery No of pages: 10
More informationTSX: LUN OMX: LUMI Corpora Corpor t a e t Presen esen a t tion
TSX: LUN OMX: LUMI Corporate Presentation November 2013 Cautionary Statements Caution Regarding Forward Looking Statements This presentation contains forward looking statements. These forward looking statements
More informationRiesling Base Metal Project pxrf Soil Geochemistry
pxrf Soil Geochemistry Ken Harvey Non-executive Director Superior Resources Limited Riesling Located 280km NW Townsville & 17km SSW of Mount Surprise, North Queensland VMS (or Broken Hill) type deposit
More informationHISTORICAL OVERVIEW OF GOLD COPPER MINERAL DISCOVERIES & MINE DEVELOPMENTS IN THE PHILIPPINES
15 10 05 120 125 120 125 15 10 05 HISTORICAL OVERVIEW OF GOLD COPPER MINERAL DISCOVERIES & MINE DEVELOPMENTS IN THE PHILIPPINES Spain China 3rd 1 th century North America Java 16 th 19 th century12 th
More informationAccelerated Mining and Gold Production Completion of Strategic Alliance with Territory Resources for Tennant Creek $2m Placement at 56.
ASX Announcement 6 September 2018 ASX: ERM Accelerated Mining and Gold Production Completion of Strategic Alliance with Territory Resources for Tennant Creek $2m Placement at 56.8% premium Highlights Emmerson
More informationKihabe Zn, Pb, Ag Project Botswana
Kihabe Zn, Pb, Ag Project Botswana 8/800 Albany Highway East Victoria Park, WA 6101 www.mountburgess.com mtb@mountburgess.com ASX: MTB Kihabe 14.4Mt Resource* Nxuu 10.9Mt Resource* * See slide 5 for Resource
More information28 April 2017 ASX Code: COY. March 2017 Quarterly Activity Report
28 April 2017 ASX Code: COY The following report details the operating and corporate activities of Coppermoly Ltd (Coppermoly or the Company) for the quarter ended 31 March 2017 and to the date of this
More informationMacmillan Pass Zinc Project: Growing an Already World-Class Asset
Macmillan Pass Zinc Project: Growing an Already World-Class Asset January 2018 Cautionary Statements The following statements are required by Canadian securities legislation: Forward-Looking Statements:
More informationTamsulosin Hydrochloride 0.4 mg Capsule
Tamsulosin Hydrochloride 0.4 mg Capsule, Tamsulosin Hydrochloride 0.4 mg Capsule India, Tamsulosin Hydrochloride 0.4 mg Capsule manufacturers India, side effects Tamsulosin Hydrochloride 0.4 mg Capsule
More informationInvestor Presentation
ASX:THC B u i l d i n g a M e d i c i n a l C a n n a b i s B u s i n e s s Investor Presentation November 2017 DISCLAIMER The material in this presentation (material) is not and does not constitute an
More informationAyawilca Zinc Project Peru: Targeting Resource Growth in 2017
Ayawilca Zinc Project Peru: Targeting Resource Growth in 2017 PDAC Peru Day Presentation Dr Graham Carman Tinka Resources Limited March 6, 2017 OTC: TKRFF Disclaimer This presentation is not directed to,
More informationSCOUT DRILLING COMPLETED ON KELLERBERRIN URANIUM PROJECT
ASX ANNOUNCEMENT SCOUT DRILLING COMPLETED ON KELLERBERRIN URANIUM PROJECT ASX Code: MDX ABN: 28 106 866 442 Corporate Description Mindax's Mt Forrest Iron Project is progressing through feasibility with
More informationInvestment in MGC Pharmaceuticals
Investment in MGC Pharmaceuticals Investor Presentation May 2015 Disclaimer This presentation has been prepared by Erin Resources Limited ( Company ). It does not purport to contain all the information
More informationFor personal use only
ASX RELEASE (23 rd March 2018) AGM PowerPoint Presentaion In accordance with the requirements of Listing Rule 3.1 we submit the attached material being distributed at the Company s Annual General Meeting
More informationOPEMISKA COPPER MINE COMPLEX. PORE: TSXV powerore.com
OPEMISKA COPPER MINE COMPLEX PORE: TSXV powerore.com FORWARD LOOKING STATEMENTS We are in the mineral exploration and development business. It is inherently risky, and all potential investors should be
More informationBISIE PROJECT UPDATE
Level 3, Gotthardstrasse 20, CH-6300, Zug, Switzerland Tel: +41 41 711 02 81 www.alphaminresources.com BISIE PROJECT UPDATE News Release 2014-10-27 VANCOUVER, CANADA October 27 th, 2014 Alphamin Resources
More informationFor personal use only
Virtus Health (ASX. VRT) Sue Channon CEO and Glenn Powers CFO Navigating Future Growth, UBS Australasian Conference 7 November, 2016 DISCLAIMER 2 The material in this presentation has been prepared by
More informationBrisa Concessão Rodoviária. 1Q 2017 Traffic Update
Brisa Concessão Rodoviária 1Q 2017 Traffic Update 15 th May 2017 Disclaimer The information contained herein ( Information ) has been prepared by Brisa Concessão Rodoviária, S.A. ("BCR") and which, according
More informationASX/Media Announcement 24 December 2010
ASX/Media Announcement 24 December 2010 ANDY WELL PROJECT UPDATE Diamond drilling continues to deliver high-grade results RC drilling continues at Wilber Lode to define a JORC Resource Southern extensions
More informationDeveloping Xanamem for Alzheimer s Dementia
Developing Xanamem for Alzheimer s Dementia Dr. Bill Ketelbey CEO, Actinogen Medical Investor Presentation March 2015 Forward Statements This presentation has been prepared by Actinogen Limited. ( Actinogen
More informationNOXOPHARM CORPORATE PRESENTATION FNN SHAW&PARTNERS INVESTOR EVENT ASX: NOX
Date: 14 August, 2018 Sydney, Australia ASX: NOX Noxopharm Limited NOXOPHARM CORPORATE PRESENTATION FNN SHAW&PARTNERS INVESTOR EVENT ABN 50 608 966 123 Registered Office and Operations Office: Suite 3,
More informationExpanding Resources in the Caribbean
TSX.V: UGD Expanding Resources in the Caribbean CORPORATE PRESENTATION; September 2017 Forward Looking Statements Certain statements contained in this presentation, including statements regarding events
More informationPXL770, a novel direct AMPK activator, improves metabolic disorders in a diet-induced mice model of obesity and diabetes
PXL770, a novel direct AMPK activator, improves metabolic disorders in a diet-induced mice model of obesity and diabetes Sébastien Bolze 1 ; Sophie Hallakou-Bozec 1 ; Michael Roden 2, 3,4 ; Julien Roux
More informationInvestor presentation. Bioshares Biotech Summit July 2017
Investor presentation Bioshares Biotech Summit 2017 22 July 2017 1 Disclaimer Some of the information in this presentation may refer to Dimerix Limited ( Dimerix or the Company ) based on information available
More informationPRELIMINARY DRILLING RESULTS FROM FIVE NEW DRILL HOLES EXTEND IRON MINERALISATION AT MARIELA
LATIN RESOURCES LIMITED ACN: 131 405 144 Suite 2, Level 1, 254 Rokeby Road Subiaco, Western Australia, 6008. P 08 9485 0601 F 08 9321 6666 E info@latinresources.com.au 30 January 2013 PRELIMINARY DRILLING
More informationNOXOPHARM POSTS CORPORATE PRESENTATION AHEAD OF CONFERENCE ASX: NOX. Presentation at Singapore Investor Conference Review of first year of operation
Date 8 August 2017 Sydney, Australia ASX: NOX Noxopharm Limited ABN 50 608 966 123 Registered Office: Suite 1 Level 6 50 Queen St Melbourne VIC 3000 Australia Operations Office: Suite 3 Level 4 828 Pacific
More informationBioxyne Launches New Zealand Dairy Formula Product in South East Asia
Suite 506, Level 5, 50 Clarence St Sydney NSW 2000 P: +61 2 9078 8180 W: www.bioxyne.com ASX RELEASE 7 December 2017 Bioxyne Launches New Zealand Dairy Formula Product in South East Asia Highlights Bioxyne
More informationImproving the lives of people with neurological conditions. Annual General Meeting Neurotech International Limited (ASX: NTI) November 2017
Improving the lives of people with neurological conditions Annual General Meeting Neurotech International Limited (ASX: NTI) November 2017 Neurotech Overview Medical device company, focussed on the development
More informationCASE STUDIES USING PORTABLE XRF ANALYSERS DURING SOIL CONTAMINATION AND MINERAL EXPLORATION PROJECTS. Todd Houlahan 21 st IGES, Dublin, Ireland, 2003
CASE STUDIES USING PORTABLE XRF ANALYSERS DURING SOIL CONTAMINATION AND MINERAL EXPLORATION PROJECTS Todd Houlahan 21 st IGES, Dublin, Ireland, 23 Introduction Use of field portable XRF on soil assessment
More informationCorporate Presentation January 2019
TSXV & BVL:TK OTCPK: TKRFF www.tinkaresources.com Corporate Presentation January 2019 Disclaimer This presentation is not directed to, or intended for distribution to or use by, any person or entity that
More information2018: Growing & De-risking the Ayawilca Zinc Project in Peru
TSXV & BVL:TK OTCPK: TKRFF www.tinkaresources.com 2018: Growing & De-risking the Ayawilca Zinc Project in Peru Corporate Presentation May 2018 Disclaimer This presentation is not directed to, or intended
More informationTSX Venture: RVV OTCQB: RVVTF
TSX Venture: RVV OTCQB: RVVTF The image part with relationship ID rid3 was not found in the file. 2017 Annual General and Special Meeting of Shareholders December 19, 2017 Revive Therapeutics Ltd. Office:
More informationClariant Mining Emulsifiers for Explosives
Clariant Mining Emulsifiers for Explosives Clariant s Solutions Clariant Mining offers customers high performance, tailor-made products that include synergistic blends and ready-to-use fuel phase solutions.
More informationNitrazepam. Nitrazepam Tablets TAJ GROUP PHARMACEUTICAL B U S I N E S S. Generics. Active Ingredients: Each tablet contains 10 mg Nitrazepam
Nitrazepam, Nitrazepam India, Nitrazepam manufacturers India, side effects Nitrazepam manufacturers, Taj Pharma India, Nitrazepam overdose, Nitrazepam drug, Nitrazepam composition, Manufacturing Pharmaceutical,
More informationPROACTIVE INVESTOR PRESENTATION
www.thcl.com.au ASX RELEASE (16 th May 2017) PROACTIVE INVESTOR PRESENTATION The Hydroponics Company Limited (ASX: THC) is pleased to advise that Dr Andrew Beehag, Chief Executive Officer of Canndeo Limited,
More informationXanADu: A Phase II trial of Xanamem TM in mild Alzheimer's disease
XanADu: A Phase II trial of Xanamem TM in mild Alzheimer's disease Dr Bill Ketelbey CEO 17TH ALZHEIMER'S AUSTRALIA BIENNIAL NATIONAL DEMENTIA CONFERENCE 19 OCTOBER 2017 Disclaimer This presentation has
More informationHow to Make a Fire Piston Cheap
1. Select a copper and brass pipe about 3 long and an end cap. 2. Cut off threaded part of bolt allowing 4 long. 3. Take a hacksaw and cut several grooves on about a quarter of an inch and large enough
More informationTHE VILLAGE AT SAVANNAH QUARTERS
THE VILLAGE AT SAVANNAH QUARTERS POOLER PARKWAY POOLER, GA 31322 Adam Bryant, CCIM Partner 912.667.2740 adam.bryant@svn.com Tom DeMint, CCIM Partner 843.816.7191 tdemint@svn.com SVN GASC 6001 CHATHAM CENTER
More informationKnowledge Discovery and Data Mining Applied to Engineering Applications
Knowledge Discovery and Data Mining Applied to Engineering Applications Shirley Williams The University of Reading 25th September 2001 (c) Shirley Williams, 2001 1 Overview The process Understanding the
More informationSkorpion Zinc: Mine-to-metal zinc production via solvent extraction
Skorpion Zinc: Mine-to-metal zinc production via solvent extraction Kathy Sole Anglo Research, South Africa Herman Fuls, Jürgen Gnoinski Skorpion Zinc, Namibia H Traditional Zinc Processing Usually present
More informationSlide 1. International Operations update. Mike Doustdar EVP International Operations. YASMIN FIEDLER, Germany Yasmin has type 1 diabetes
Slide 1 International Operations update Mike Doustdar EVP International Operations YASMIN FIEDLER, Germany Yasmin has type 1 diabetes Slide 2 Forward-looking statements Novo Nordisk s reports filed with
More informationAvailable online at ScienceDirect. Procedia Environmental Sciences 31 (2016 )
Available online at www.sciencedirect.com ScienceDirect Procedia Environmental Sciences 31 (2016 ) 195 203 The Tenth International Conference on Waste Management and Technology (ICWMT) Study of new process
More informationFor personal use only OSPREY MEDICAL INC EXECUTIVE SUMMARY Q1 2015
OSPREY MEDICAL INC EXECUTIVE SUMMARY Q1 2015 Disclaimer This presentation has been prepared by Osprey Medical, Inc. ( Osprey or the Company ) for the sole purpose of providing general and background information
More informationAnnual Results 2017 & Business Update 13 April 2018
Annual Results 2017 & Business Update 13 April 2018 1 Disclaimer These slides and the accompanying oral presentation contain forward-looking statements and information. Forward-looking statements are subject
More informationPassion for progress, care for people
Passion for progress, care for people SPIL Analyst Meeting 25 th April, 2008 DISCLAIMER ACTUAL RESULTS / OUTCOMES MAY BE DIFFERENT FROM ANY FORWARD LOOKING STATEMENTS / VIEWS / ESTIMATES EXPRESSED HEREIN.
More informationVisionary Private Equity Group is Pleased to Announce its Investment in MEDITE Cancer Diagnostics
Dear VPEG Limited Partner, We hope this investor update finds you well. We're pleased to share with you an important update below on the following: Visionary Private Equity Group is Pleased to Announce
More informationImportant Notices. BASIS CPD Points PN/50971/1516/g
Chilli pepper results May 2016 1 Important Notices BASIS CPD Points PN/50971/1516/g This document is produced for information only and not in connection with any specific or proposed offer (the Offer )
More informationAcquisition of Novartis Influenza Vaccines Business. 27 th October 2014
1 Acquisition of Novartis Influenza Vaccines Business 27 th October 2014 2 Legal Notice Forward looking statements The materials in this presentation speak only as of the date of these materials, and include
More informationNovo Nordisk has proposed to acquire Ablynx for up to per share in cash, consisting of upfront and 2.50 in Contingent Value Rights
Novo Nordisk has proposed to acquire Ablynx for up to 30.50 per share in cash, consisting of 28.00 upfront and 2.50 in Contingent Value Rights Proposal consists of upfront cash consideration of 28.00 per
More informationDistal Radius Sterile Kit. Optimization And Efficiency You Can Rely On
Distal Radius Sterile Kit Optimization And Efficiency You Can Rely On Introducing The Distal Radius Sterile Kit Improved OR Workflow The Distal Radius Sterile Kit provides high-quality single-use implants
More informationMDxHealth. Excellent Buy Opportunity. Research Note.
Research Note MDxHealth Excellent Buy Opportunity Chief Research Analyst Marcel Wijma MSc +1 (917) 460 6185 (US) +31 (6) 8489 2954 (NL) m.wijma@leeuwenhoeck.com http://www.leeuwenhoeck.com Date: 29 February
More informationHELPING THE WORLD WORK. DUST METAL OXIDE FINES USZINC.com
HELPING THE WORLD WORK DUST METAL OXIDE FINES USZINC.com Headquartered in Houston, Texas for more than 65 years, U.S. Zinc has grown into the premier global leader in the added value zinc products market.
More informationSprott Investment Conference July 17-20, Booth 6
Sprott Investment Conference July 17-20, 2018 Booth 6 Forward Looking Statements This presentation contains forward-looking information that involves substantial known and unknown risks and uncertainties,
More informationAdvancing Pancreatic & Liver Cancer Treatment
ASX.OSL Advancing Pancreatic & Liver Cancer Treatment Australian Biotech Invest 2017 October 24 th Melbourne 1 Important notice This Presentation has been prepared by Ltd (ASX:OSL) (OncoSil or the Company)
More informationImperial Brands Maximising Category Opportunities CAGNY February 2019
Imperial Brands Maximising Category Opportunities CAGNY 2019 21 February 2019 Disclaimer Certain statements in this announcement constitute or may constitute forward-looking statements. Any statement in
More informationUSER SPECIFICATIONS FOR QUINTOLUBRIC 888 Series DESCRIPTION OF THE MOST IMPORTANT PROPERTIES AND THE POSSIBLE VARIATIONS AND TOLERANCES
USER SPECIFICATIONS FOR QUINTOLUBRIC 888 Series OVERVIEW The QUINTOLUBRIC 888 Series of fluids are based on a synthetic organic ester, which is the main base component, plus a number of selected additives
More informationMagellan s Transport Route Lead Monitoring Program
Magellan s Transport Route Lead Monitoring Program Magellan s lead monitoring requirements Magellan s approval to export sealed shipments of lead carbonate through Fremantle is subject to the Interim Implementation
More informationEKOS. Interventional Vascular 3 February, Imagine where we can go.
EKOS Interventional Vascular 3 February, 2015 Imagine where we can go. Forward-looking statement This presentation and information communicated verbally to you may contain certain projections and other
More informationFor personal use only. A new company with: a new technology platform for cancer drug development a new management team a new Board
A new company with: a new technology platform for cancer drug development a new management team a new Board Disclaimer This presentation is confidential and is not an offer or a recommendation or intended
More informationUniversal Biosensors, Inc.
Universal Biosensors, Inc. ARBN 121 559 993 Buchan Three Tickers Presentation 18 th September 2013 1 Important Disclaimer This presentation is intended to provide a general outline only and is not intended
More informationWHAT NEIGHBORS WANT TO KNOW ABOUT RETAIL MARIJUANA. In Aurora
WHAT NEIGHBORS WANT TO KNOW ABOUT RETAIL MARIJUANA In Aurora WWW.AURORAGOV.ORG/AMED LEGALIZING RETAIL MARIJUANA IN COLORADO In 2010, Aurora voters opposed a ballot question that would have allowed medical
More informationShea Clark Smith / MEG, Inc., P.O. Box 18325, Reno, Nevada, USA Tel:
MEG-Au.13.01 (0.31 ppm Au) n = 57 Ag As Cu Fe Mn Pb S Sb Zn SAMPLES AVG = 0.308 MAX = 0.334 ppm ppm ppm % ppm ppm % ppm ppm LABS AVG = 0.308 MIN = 0.282 0.833 70 30 2.7 1400 50 1.50 4 130 MEAN + SD = 0.322
More informationPORTFOLIO UNIT COST (C$) BOOK VALUE (C$) PRICE UNITS MARKET VALUE (C$) MFABC SHORT TRM BOND ,265, ,926, ,265,266.
ACCOUNT STATEMENT CITY OF WEST VANCOUVER September 30, 2015 Account #: 200000196-20 Cross-reference #: 875-1 Account Type: Non-Registered ACCOUNT SUMMARY AS OF SEPTEMBER 30, 2015 PORTFOLIO UNIT COST (C$)
More informationScenario of Castor Seed
Scenario of Castor Seed Castor (Ricinus communis L.) is a non edible oilseed, belonging to the Euphorbiaceae family. India is the leader in global castor production and dominates in international castor
More information2015 outlook for base metals. Moderated by: Garry Jones Chief Executive Officer, LME
20 October, 2014 2015 outlook for base metals Moderated by: Garry Jones Chief Executive Officer, LME Zinc market outlook balance of opinion vs balance of material LME metals seminar London 20 October 2014
More informationACACIA PHARMA ANNOUNCES ITS INTENTION TO LAUNCH AN INITIAL GLOBAL OFFERING AND TO LIST ITS SHARES ON EURONEXT BRUSSELS
This announcement is an advertisement for the purposes of the Prospectus Rules of the Financial Conduct Authority ( FCA ) and not a prospectus and not an offer of securities for sale in any jurisdiction,
More informationSpiros Nomikos Chief Executive Officer Solvay Sodi Bulgaria
Spiros Nomikos Chief Executive Officer Solvay Sodi Bulgaria FINANCIAL TIMES INVESTING IN BULGARIA CONFERENCE Investment Opportunities in Bulgaria The Case of Solvay Sodi Spiros Nomikos CEO of Solvay Sodi
More informationCavosonstat Phase 2 Trial Results. November 28 th, 2016
Phase 2 Trial Results November 28 th, 2016 Nivalis Therapeutics 2016 Agenda Introduction Mike Carruthers, Chief Financial Officer Initial Remarks Jon Congleton, President and CEO Data Highlights David
More informationTelekom Austria Group Results for the 1st Quarter May 27, 2003
Telekom Austria Group Results for the 1st Quarter 2003 May 27, 2003 1 Cautionary Statement This presentation contains certain forward-looking statements. Actual results may differ materially from those
More informationFor personal use only
L1, 254 Railway Parade, West Leederville WA 6007 PO Box 1245, West Leederville WA 6901 T: +61 8 9363 7800 e: office@platypusminerals.com.au www.platypusminerals.com.au ASX/Media Announcement Perth: 18
More informationDR.NEIL FRAZER CHIEF EXECUTIVE OFFICER & MANAGING 1
DR.NEIL FRAZER CHIEF EXECUTIVE OFFICER & MANAGING DIRECTOR @Dr_Neil_Frazer 1 IMPORTANT NOTICE The purpose of the presentation is to provide an update of the business of OncoSil Medical Ltd (ASX:OSL). These
More informationSMARTLockTM. Hybrid MMFTM
SMARTLockTM Hybrid MMFTM Hybrid MMF Make a smart choice in MMF Designed to combine the strength and rigidity of arch bars with the safety and efficiency of MMF screws, our Hybrid MMF system is a smart
More informationOrganisational reporting of completion fees apply
Self reporting of completion free service Proof of completion of all courses is provided to all learners in the form of a printable and emailable Certificate of Completion. Learners can use these certificates
More informationGert Heylen Head of Genk Plant
Site visit 07 Genk plant June 7 th, 07 Bernard Hallemans Chief Operating Officer Europe Gert Heylen Head of Genk Plant Disclaimer Forward-Looking Statements This document may contain forward-looking information
More informationIncorporating bioavailability into regulatory practice
Incorporating bioavailability into regulatory practice Experiences with metals in water Helen Wilkinson and Paul Whitehouse Evidence Directorate Environment Agency Outline Environmental Quality Standards
More informationTransforming IVF and Biological Separations Presentation by Executive Chairman, Alison Coutts
Transforming IVF and Biological Separations Presentation by Executive Chairman, Alison Coutts NuSep (ASX:NSP) key facts No. shares 237,606,002 Market Cap. $7.1 million (@3 cps) No. of shareholders Approx.
More informationUNDERSTANDING THE ROLE OF WOMEN AND GIRLS IN RENEWABLE AND ENERGY- EFFICIENCY PROJECTS IN-DEPTH STUDY III GENDER IN THE EEP PORTFOLIO / SUMMARY REPORT
1 UNDERSTANDING THE ROLE OF WOMEN AND GIRLS IN RENEWABLE AND ENERGY- EFFICIENCY PROJECTS IN-DEPTH STUDY III GENDER IN THE EEP PORTFOLIO / SUMMARY REPORT The Energy and Environment Partnership Programme
More informationA ZINC MINER IN THE MAKING
A ZINC MINER IN THE MAKING May 2013 Cautionary Disclaimer FORWARD LOOKING STATEMENT 2 This presentation contains forward looking statements; including in particular, statements about Firestone Ventures
More informationThe Dental Corporation Opportunity
The Dental Corporation Opportunity for Practice Principals. It s the perfect professional collaboration. You focus on dentistry, we look after the paperwork. In recognition of what you, the Practice Principal,
More informationPRESENTATION. AGM 27 th OCTOBER 2015 ASX: PAA ACN
PRESENTATION AGM 27 th OCTOBER 2015 ASX: PAA ACN 094 006 023 Disclaimer This presentation does not constitute investment advice. Neither this presentation nor the information contained in it constitutes
More informationDMX-200 for Diabetic Kidney Disease
DMX-200 for Diabetic Kidney Disease A/Prof David Packham MBBS(Hons), FRCP, FRACP, ARCP, MD Chief Medical Officer, Dimerix Nephrologist Bioshares Summit Queenstown, New Zealand 27 July 2018 Disclaimer Some
More informationCeltic Sea Minerals. Natural, bio-available minerals from the seabed
Celtic Sea Minerals Natural, bio-available minerals from the seabed Celtic Sea Minerals Celtic Sea Minerals specialises in the development, manufacture and marketing of natural animal feed, hygiene and
More informationGF China Commodities Weekly
GF China Commodities Weekly CHINA ZINC CONCENTRATE SUPPLY WILL BE MORE DEPENDENT ON DOMESTIC MARKETIN 2H16 GFF Commodities Research Contacts : Bonnie Liu;852-3719 1155;bonnieliu@gfgroup.com.hk Zhang Ruoyi;020-85594189;zhangruoyi@gf.com.cn
More information36th Annual J.P. Morgan Healthcare Conference. Kevin Conroy, Chairman and CEO January 9, 2018
36th Annual J.P. Morgan Healthcare Conference Kevin Conroy, Chairman and CEO January 9, 2018 1 Safe harbor statement This presentation contains forward-looking statements within the meaning of Section
More informationCERTIFICATE OF COMPLIANCE SGS United Kingdom A UKAS Accredited Test House
SGS United Kingdom Ltd. Consumer Testing Services Units 41 & 43, Listerhills Park of Science and Commerce, Campus Road, Bradford, West Yorkshire, United Kingdom BD7 1HR Tel : +44 (0)1274-303080 Fax :+44
More informationGrowth of s 1 lac invested on inception date. SIP Performance: Scheme Name 1 Yr 2 Yr 3 Yr 4 Yr 5 Yr. CNX Midcap
BNP Paribas Midcap The investment objective of the is to seek to generate long-term capital appreciation by investing primarily in companies with high growth opportunities in the middle and small capitalization
More informationPLEO-CMT Top-line Results. Presentation October 16, 2018
PLEO-CMT Top-line Results Presentation October 16, 2018 Disclaimer References herein to this presentation (the Presentation ) shall mean and include this document, any oral presentation accompanying this
More informationFor personal use only
INVESTOR DAY & SITE TOUR 30 APRIL 2015 DISCLAIMER The presentation has been prepared by Monash IVF Group Limited (ACN 169 302 309) ( MVF ) (including its subsidiaries, affiliates and associated companies)
More informationAggregation and Diversification of Risks in the Solvency II Framework
Aggregation and Diversification of Risks in the Solvency II Framework Damir Filipović Vienna Institute of Finance University of Vienna and Vienna University of Economics and Business Administration Croatian
More informationNET LEASE PORTFOLIO INVESTMENT OPPORTUNITY
NET LEASE PORTFOLIO INVESTMENT OPPORTUNITY Walgreens Portfolio Three Properties Knoxville, TN Port Orchard, WA Cincinnati, OH Available on an Individual or Portfolio Basis DISCLAIMER STATEMENT DISCLAIMER
More informationWorld leader in navigated, non-invasive brain stimulation therapy and diagnosis
World leader in navigated, non-invasive brain stimulation therapy and diagnosis Martin Jamieson CEO & Chairman of the Board Nexstim Plc Mikko Karvinen CFO Nexstim Plc Corporate Presentation, BioTrinity,
More informationFor personal use only
Total Face Group Level 4, Bank House 11 19 Bank Place Melbourne 3000 www.totalfacegroup.com.au TOTAL FACE GROUP LTD 17th March 2016 Australian Securities Exchange Company Announcement Office Stock Exchange
More information37 th ANNUAL JP MORGAN HEALTHCARE CONFERENCE
37 th ANNUAL JP MORGAN HEALTHCARE CONFERENCE January 2019 Safe Harbor Statement This presentation contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as
More information